ID   CATL2_HUMAN             Reviewed;         334 AA.
AC   O60911; O60233; Q2TB86; Q5T1U0;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Cathepsin L2;
DE            EC=3.4.22.43;
DE   AltName: Full=Cathepsin U;
DE   AltName: Full=Cathepsin V;
DE   Flags: Precursor;
GN   Name=CTSV; Synonyms=CATL2, CTSL2, CTSU; ORFNames=UNQ268/PRO305;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9563472;
RA   Santamaria I., Velasco G., Cazorla M., Fueyo A., Campo E.,
RA   Lopez-Otin C.;
RT   "Cathepsin L2, a novel human cysteine proteinase produced by breast
RT   and colorectal carcinomas.";
RL   Cancer Res. 58:1624-1630(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Corneal epithelium;
RX   PubMed=9727401;
RA   Adachi W., Kawamoto S., Ohno I., Nishida K., Kinoshita S.,
RA   Matsubara K., Okubo K.;
RT   "Isolation and characterization of human cathepsin V: a major
RT   proteinase in corneal epithelium.";
RL   Invest. Ophthalmol. Vis. Sci. 39:1789-1796(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Kidney, and Thymus;
RX   PubMed=10029531; DOI=10.1021/bi982175f;
RA   Broemme D., Li Z., Barnes M., Mehler E.;
RT   "Human cathepsin V functional expression, tissue distribution,
RT   electrostatic surface potential, enzymatic characterization, and
RT   chromosomal localization.";
RL   Biochemistry 38:2377-2385(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10382972; DOI=10.1093/dnares/6.2.137;
RA   Itoh R., Kawamoto S., Adachi W., Kinoshita S., Okubo K.;
RT   "Genomic organization and chromosomal localization of the human
RT   cathepsin L2 gene.";
RL   DNA Res. 6:137-140(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   GLYCOSYLATION AT ASN-221 AND ASN-292.
RX   PubMed=22967898; DOI=10.1016/j.febslet.2012.08.001;
RA   Niwa Y., Suzuki T., Dohmae N., Umezawa K., Simizu S.;
RT   "Determination of cathepsin V activity and intracellular trafficking
RT   by N-glycosylation.";
RL   FEBS Lett. 586:3601-3607(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=11027133; DOI=10.1021/bi000951p;
RA   Somoza J.R., Zhan H., Bowman K.K., Yu L., Mortara K.D., Palmer J.T.,
RA   Clark J.M., McGrath M.E.;
RT   "Crystal structure of human cathepsin V.";
RL   Biochemistry 39:12543-12551(2000).
RN   [11]
RP   ERRATUM.
RA   Somoza J.R., Zhan H., Bowman K.K., Yu L., Mortara K.D., Palmer J.T.,
RA   Clark J.M., McGrath M.E.;
RL   Biochemistry 40:4200-4200(2001).
CC   -!- FUNCTION: Cysteine protease. May have an important role in corneal
CC       physiology. {ECO:0000269|PubMed:10029531,
CC       ECO:0000269|PubMed:9727401}.
CC   -!- CATALYTIC ACTIVITY: The recombinant enzyme hydrolyzes proteins
CC       (serum albumin, collagen) and synthetic substrates (Z-Phe-Arg-
CC       NHMec > Z-Leu-Arg-NHMec > Z-Val-Arg-NHMec).
CC       {ECO:0000269|PubMed:10029531}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the thymus and
CC       testis. Also expressed in corneal epithelium, and to a lesser
CC       extent in conjunctival epithelium and skin.
CC       {ECO:0000269|PubMed:10029531, ECO:0000269|PubMed:9563472,
CC       ECO:0000269|PubMed:9727401}.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y14734; CAA75029.1; -; mRNA.
DR   EMBL; AB001928; BAA25909.1; -; mRNA.
DR   EMBL; AF070448; AAC23598.1; -; mRNA.
DR   EMBL; AB019534; BAA34365.1; -; Genomic_DNA.
DR   EMBL; AY358641; AAQ89004.1; -; mRNA.
DR   EMBL; AL445670; CAI15053.1; -; Genomic_DNA.
DR   EMBL; BC023504; AAH23504.1; -; mRNA.
DR   EMBL; BC110512; AAI10513.1; -; mRNA.
DR   CCDS; CCDS6723.1; -.
DR   RefSeq; NP_001188504.1; NM_001201575.1.
DR   RefSeq; NP_001324.2; NM_001333.3.
DR   UniGene; Hs.610096; -.
DR   PDB; 1FH0; X-ray; 1.60 A; A/B=114-334.
DR   PDB; 3H6S; X-ray; 2.22 A; A/B/C/D=114-334.
DR   PDB; 3KFQ; X-ray; 1.99 A; A/B=114-334.
DR   PDBsum; 1FH0; -.
DR   PDBsum; 3H6S; -.
DR   PDBsum; 3KFQ; -.
DR   ProteinModelPortal; O60911; -.
DR   SMR; O60911; -.
DR   BioGrid; 107895; 22.
DR   IntAct; O60911; 15.
DR   MINT; MINT-2797137; -.
DR   STRING; 9606.ENSP00000259470; -.
DR   BindingDB; O60911; -.
DR   ChEMBL; CHEMBL3272; -.
DR   DrugBank; DB02869; 3-amino-5-phenylpentane.
DR   DrugBank; DB04451; 4-Methylpiperazin-1-Yl Carbonyl Group.
DR   GuidetoPHARMACOLOGY; 2352; -.
DR   MEROPS; I29.010; -.
DR   iPTMnet; O60911; -.
DR   PhosphoSitePlus; O60911; -.
DR   BioMuta; CTSV; -.
DR   EPD; O60911; -.
DR   MaxQB; O60911; -.
DR   PaxDb; O60911; -.
DR   PeptideAtlas; O60911; -.
DR   PRIDE; O60911; -.
DR   Ensembl; ENST00000259470; ENSP00000259470; ENSG00000136943.
DR   Ensembl; ENST00000538255; ENSP00000445052; ENSG00000136943.
DR   GeneID; 1515; -.
DR   KEGG; hsa:1515; -.
DR   UCSC; uc004awt.4; human.
DR   CTD; 1515; -.
DR   DisGeNET; 1515; -.
DR   GeneCards; CTSV; -.
DR   HGNC; HGNC:2538; CTSV.
DR   HPA; CAB017112; -.
DR   MIM; 603308; gene.
DR   neXtProt; NX_O60911; -.
DR   OpenTargets; ENSG00000136943; -.
DR   PharmGKB; PA27036; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00760000118871; -.
DR   HOGENOM; HOG000230774; -.
DR   HOVERGEN; HBG011513; -.
DR   InParanoid; O60911; -.
DR   KO; K01375; -.
DR   OMA; ANEEGWR; -.
DR   OrthoDB; EOG091G0AKT; -.
DR   PhylomeDB; O60911; -.
DR   TreeFam; TF313739; -.
DR   BRENDA; 3.4.22.43; 2681.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   SABIO-RK; O60911; -.
DR   EvolutionaryTrace; O60911; -.
DR   GeneWiki; Cathepsin_L2; -.
DR   GenomeRNAi; 1515; -.
DR   PRO; PR:O60911; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136943; -.
DR   CleanEx; HS_CTSL2; -.
DR   ExpressionAtlas; O60911; baseline and differential.
DR   Genevisible; O60911; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0030141; C:secretory granule; IEA:Ensembl.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:Ensembl.
DR   GO; GO:0016807; F:cysteine-type carboxypeptidase activity; IEA:Ensembl.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0042393; F:histone binding; IEA:Ensembl.
DR   GO; GO:0030984; F:kininogen binding; IEA:Ensembl.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0048102; P:autophagic cell death; IEA:Ensembl.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
DR   GO; GO:0046697; P:decidualization; IEA:Ensembl.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
DR   GO; GO:0010259; P:multicellular organism aging; IEA:Ensembl.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IEA:Ensembl.
DR   GO; GO:0021675; P:nerve development; IEA:Ensembl.
DR   GO; GO:0016540; P:protein autoprocessing; IEA:Ensembl.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0034698; P:response to gonadotropin; IEA:Ensembl.
DR   GO; GO:1990834; P:response to odorant; IEA:Ensembl.
DR   GO; GO:0060008; P:Sertoli cell differentiation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Hydrolase; Lysosome; Protease; Reference proteome; Signal;
KW   Thiol protease; Zymogen.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   PROPEP       18    113       Activation peptide.
FT                                /FTId=PRO_0000026277.
FT   CHAIN       114    334       Cathepsin L2.
FT                                /FTId=PRO_0000026278.
FT   ACT_SITE    138    138       {ECO:0000269|PubMed:11027133}.
FT   ACT_SITE    277    277       {ECO:0000269|PubMed:11027133}.
FT   ACT_SITE    301    301       {ECO:0000269|PubMed:11027133}.
FT   CARBOHYD    221    221       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22967898}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22967898}.
FT   DISULFID    135    178
FT   DISULFID    169    211
FT   DISULFID    270    323
FT   CONFLICT     81     81       G -> P (in Ref. 1; CAA75029).
FT                                {ECO:0000305}.
FT   HELIX       120    123       {ECO:0000244|PDB:1FH0}.
FT   HELIX       138    155       {ECO:0000244|PDB:1FH0}.
FT   HELIX       163    169       {ECO:0000244|PDB:1FH0}.
FT   HELIX       171    173       {ECO:0000244|PDB:1FH0}.
FT   HELIX       177    179       {ECO:0000244|PDB:1FH0}.
FT   HELIX       183    193       {ECO:0000244|PDB:1FH0}.
FT   STRAND      196    198       {ECO:0000244|PDB:1FH0}.
FT   TURN        199    201       {ECO:0000244|PDB:1FH0}.
FT   HELIX       215    217       {ECO:0000244|PDB:1FH0}.
FT   STRAND      218    220       {ECO:0000244|PDB:1FH0}.
FT   STRAND      225    227       {ECO:0000244|PDB:1FH0}.
FT   HELIX       233    242       {ECO:0000244|PDB:1FH0}.
FT   STRAND      246    250       {ECO:0000244|PDB:1FH0}.
FT   HELIX       255    258       {ECO:0000244|PDB:1FH0}.
FT   STRAND      262    265       {ECO:0000244|PDB:1FH0}.
FT   STRAND      272    274       {ECO:0000244|PDB:3H6S}.
FT   STRAND      277    289       {ECO:0000244|PDB:1FH0}.
FT   STRAND      293    300       {ECO:0000244|PDB:1FH0}.
FT   STRAND      312    316       {ECO:0000244|PDB:1FH0}.
FT   STRAND      318    321       {ECO:0000244|PDB:1FH0}.
FT   HELIX       322    324       {ECO:0000244|PDB:1FH0}.
FT   TURN        325    327       {ECO:0000244|PDB:1FH0}.
FT   STRAND      330    332       {ECO:0000244|PDB:1FH0}.
SQ   SEQUENCE   334 AA;  37329 MW;  CD2DE51AC5F242C8 CRC64;
     MNLSLVLAAF CLGIASAVPK FDQNLDTKWY QWKATHRRLY GANEEGWRRA VWEKNMKMIE
     LHNGEYSQGK HGFTMAMNAF GDMTNEEFRQ MMGCFRNQKF RKGKVFREPL FLDLPKSVDW
     RKKGYVTPVK NQKQCGSCWA FSATGALEGQ MFRKTGKLVS LSEQNLVDCS RPQGNQGCNG
     GFMARAFQYV KENGGLDSEE SYPYVAVDEI CKYRPENSVA NDTGFTVVAP GKEKALMKAV
     ATVGPISVAM DAGHSSFQFY KSGIYFEPDC SSKNLDHGVL VVGYGFEGAN SNNSKYWLVK
     NSWGPEWGSN GYVKIAKDKN NHCGIATAAS YPNV
//
